↓ Skip to main content

Harm, hype and evidence: ELSI research and policy guidance

Overview of attention for article published in Genome Medicine, March 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
blogs
3 blogs
twitter
44 X users
googleplus
1 Google+ user

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Harm, hype and evidence: ELSI research and policy guidance
Published in
Genome Medicine, March 2013
DOI 10.1186/gm425
Pubmed ID
Authors

Timothy Caulfield, Subhashini Chandrasekharan, Yann Joly, Robert Cook-Deegan

Abstract

There has been much investment in research on the ethical, legal and social issues (ELSI) associated with genetic and genomic research. This research should inform the development of the relevant policy. So far, much of the relevant policy - such as in the areas of patents, genetic testing and genetic discrimination - seems to be informed more by speculation of harm and anecdote than by available evidence. Although a quest for evidence cannot always be allowed to delay policy choice, it seems axiomatic to us that policy options are improved by the incorporation of evidence.

X Demographics

X Demographics

The data shown below were collected from the profiles of 44 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
United Kingdom 1 2%
Belgium 1 2%
Canada 1 2%
Unknown 45 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Ph. D. Student 8 16%
Student > Master 7 14%
Student > Bachelor 5 10%
Other 4 8%
Other 10 20%
Unknown 6 12%
Readers by discipline Count As %
Medicine and Dentistry 14 28%
Social Sciences 11 22%
Agricultural and Biological Sciences 9 18%
Biochemistry, Genetics and Molecular Biology 3 6%
Philosophy 2 4%
Other 3 6%
Unknown 8 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2021.
All research outputs
#731,500
of 25,373,627 outputs
Outputs from Genome Medicine
#139
of 1,585 outputs
Outputs of similar age
#4,952
of 210,385 outputs
Outputs of similar age from Genome Medicine
#3
of 24 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,385 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.